FDA announced a virtual meeting of its Vaccines and Related Biological Products Advisory Committee on Feb. 15 to discuss the request for emergency use authorization of the Pfizer-BioNTech COVID-19 Vaccine for use in children 6 months through 4 years of age.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/YdJst5Aw1
No comments:
Post a Comment